<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 5:  Drugs That May Decrease Conversion of T<sub>4</sub> to T<sub>3</sub>
</caption>
<col align="left" valign="top" width="40%"></col>
<col align="left" valign="top" width="60%"></col>
<thead>
<tr>
<th align="center" stylecode="Lrule Rrule">Drug or Drug Class</th>
<th align="center" stylecode="Rrule">Effect</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="2">Potential impact: Administration of these enzyme inhibitors decreases the peripheral conversion of T<sub>4</sub> to T<sub>3</sub>, leading to decreased T<sub>3</sub> levels. However, serum T<sub>4</sub> levels are usually normal but may occasionally be slightly increased.</td>
</tr>
</tfoot>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Beta-adrenergic antagonists<br/>(e.g., Propranolol &gt; 160 mg/day)</td>
<td stylecode="Rrule">In patients treated with large doses of propranolol (&gt; 160 mg/day), T<sub>3</sub> and T<sub>4</sub> levels change slightly, TSH levels remain normal, and patients are clinically euthyroid. It should be noted that actions of particular beta-adrenergic antagonists may be impaired when the hypothyroid patient is converted to the euthyroid state. </td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Glucocorticoids<br/>(e.g., Dexamethasone â‰¥ 4 mg/day)</td>
<td stylecode="Rrule">Short-term administration of large doses of glucocorticoids may decrease serum T<sub>3</sub> concentrations by 30% with minimal change in serum T<sub>4</sub> levels. However, long-term glucocorticoid therapy may result in slightly decreased T<sub>3</sub> and T<sub>4</sub> levels due to decreased TBG production (See above).</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Other:<br/>Amiodarone</td>
<td stylecode="Rrule"></td>
</tr>
</tbody>
</table>